Kane Financial Statements From 2010 to 2026

Stocks . Canada . 
Stock . Kane Biotech
KNE Stock  CAD 0.04  0.00  0.00%   
Kane Biotech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Kane Biotech's valuation are provided below:
Gross Profit
-95.4 K
Market Capitalization
6.7 M
Enterprise Value Revenue
14.007
Revenue
574.9 K
Quarterly Revenue Growth
(0.99)
There are over one hundred nineteen available fundamental ratios for Kane Biotech, which can be analyzed over time and compared to other ratios. All traders should should check Kane Biotech's last-minute fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Enterprise Value is likely to climb to about 15.7 M in 2026, whereas Market Cap is likely to drop slightly above 6.9 M in 2026.

Kane Biotech Total Revenue

2.51 Million

Check Kane Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kane Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 288.1 K, Total Revenue of 2.5 M or Gross Profit of 1.1 M, as well as many indicators such as Price To Sales Ratio of 7.73, Dividend Yield of 0.0 or Days Sales Outstanding of 16.88. Kane financial statements analysis is a perfect complement when working with Kane Biotech Valuation or Volatility modules.
  
This module can also supplement various Kane Biotech Technical models . Check out the analysis of Kane Biotech Correlation against competitors.

Kane Biotech Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.7 M2.9 M3 M
Slightly volatile
Total Current Liabilities1.7 M2.8 M2.2 M
Slightly volatile
Property Plant And Equipment Net1.1 M1.1 M445 K
Slightly volatile
Accounts Payable1.4 M1.4 M477.6 K
Slightly volatile
Cash392 K412.6 K828.2 K
Slightly volatile
Non Current Assets Total1.3 M1.7 M1.4 M
Slightly volatile
Cash And Short Term Investments845.9 K861.6 K904.3 K
Very volatile
Net Receivables15 K15.7 K281.6 K
Pretty Stable
Common Stock Shares Outstanding166.4 M158.5 M75.3 M
Slightly volatile
Liabilities And Stockholders Equity6.9 M6.5 M3.7 M
Slightly volatile
Other Stockholder Equity6.6 M8.9 M6.5 M
Very volatile
Total Liabilities2.4 M4.7 M3.2 M
Slightly volatile
Total Current Assets1.5 M1.2 M1.7 M
Slightly volatile
Accumulated Other Comprehensive Income153.6 K161.7 K557.1 K
Pretty Stable
Intangible Assets837 K616.5 K792.2 K
Very volatile
Inventory342.6 K432.4 K270 K
Slightly volatile
Other Current Assets270.4 K236.8 K246.7 K
Slightly volatile
Common Stock18.4 M27.2 M17 M
Slightly volatile
Short and Long Term Debt Total11.1 M10.6 M3.4 M
Slightly volatile
Other Current Liabilities131.1 K138 K558.2 K
Slightly volatile
Non Current Liabilities Total1.5 M2 M1.2 M
Slightly volatile
Property Plant Equipment1.5 M1.4 M518.4 K
Slightly volatile
Other Liabilities623.9 K962.9 K617.6 K
Slightly volatile
Current Deferred Revenue907.3 K864.1 K256.7 K
Slightly volatile
Capital Stock23.9 M28.1 M20.3 M
Slightly volatile
Other Assets786.7 K510.8 K333.9 K
Slightly volatile
Capital Lease Obligations781.3 K1 M364.6 K
Slightly volatile
Property Plant And Equipment Gross1.4 M1.9 M773.8 K
Slightly volatile

Kane Biotech Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization288.1 K274.4 K118.1 K
Slightly volatile
Total Revenue2.5 M2.4 M996.2 K
Slightly volatile
Other Operating Expenses2.7 M4.6 M3.4 M
Slightly volatile
Research Development2.1 M2 M960.3 K
Slightly volatile
Total Operating Expenses7.2 M6.9 M3.6 M
Slightly volatile
Selling General Administrative2.3 M3.5 M2.3 M
Slightly volatile
Interest Expense658.7 K627.3 K298.1 K
Slightly volatile
Interest Income5.4 K5.7 K25.8 K
Slightly volatile
Reconciled Depreciation164.9 K251.2 K123.6 K
Slightly volatile

Kane Biotech Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow852.8 K1.3 M902.9 K
Slightly volatile
Depreciation263.8 K251.2 K114.5 K
Slightly volatile
Capital Expenditures158.6 K103.7 K138.8 K
Very volatile
End Period Cash Flow392 K412.6 K828.2 K
Slightly volatile
Stock Based Compensation858.3 K817.5 K330.1 K
Slightly volatile
Sale Purchase Of Stock1.8 M3 M1.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.738.1433.4766
Slightly volatile
Days Sales Outstanding16.8817.77279
Pretty Stable
Average Payables766.9 K730.4 K396.5 K
Slightly volatile
Stock Based Compensation To Revenue2.82.671.3773
Slightly volatile
Capex To Depreciation0.120.132.0764
Slightly volatile
EV To Sales8.759.2137.7871
Very volatile
Inventory Turnover3.042.891.3927
Slightly volatile
Days Of Inventory On Hand97.08102454
Very volatile
Payables Turnover0.820.920.8125
Slightly volatile
Sales General And Administrative To Revenue1.621.77.6561
Pretty Stable
Average Inventory278.9 K281.9 K277 K
Slightly volatile
Research And Ddevelopement To Revenue1.021.073.01
Very volatile
Capex To Revenue0.0130.01370.6352
Slightly volatile
Cash Per Share0.00290.00310.049
Slightly volatile
Days Payables Outstanding306322993
Slightly volatile
Income Quality0.671.170.8489
Pretty Stable
Intangibles To Total Assets0.420.250.3258
Slightly volatile
Current Ratio0.470.493.3866
Slightly volatile
Receivables Turnover22.3221.268.0411
Slightly volatile
Capex Per Share2.0E-42.0E-40.0038
Slightly volatile
Average Receivables39.3 K41.4 K236.6 K
Pretty Stable
Revenue Per Share0.01140.01790.0116
Pretty Stable
Interest Debt Per Share0.0190.01910.0218
Slightly volatile
Debt To Assets0.460.830.5107
Slightly volatile
Operating Cycle110116618
Very volatile
Days Of Payables Outstanding306322993
Slightly volatile
Ebt Per Ebit1.111.141.0095
Pretty Stable
Quick Ratio0.30.313.2523
Slightly volatile
Net Income Per E B T1.060.780.9528
Pretty Stable
Cash Ratio0.160.172.8181
Slightly volatile
Days Of Inventory Outstanding97.08102454
Very volatile
Days Of Sales Outstanding16.8817.77279
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.221.161.0935
Very volatile
Fixed Asset Turnover3.632.025.0198
Very volatile
Debt Ratio0.460.830.5107
Slightly volatile
Price Sales Ratio7.738.1433.4766
Slightly volatile
Asset Turnover0.790.750.2798
Slightly volatile
Gross Profit Margin0.360.380.9914
Pretty Stable

Kane Biotech Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap6.9 M13.3 M9.6 M
Slightly volatile
Enterprise Value15.7 M15 M11.1 M
Slightly volatile

About Kane Biotech Financial Statements

Kane Biotech investors use historical fundamental indicators, such as Kane Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kane Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue864.1 K907.3 K
Total Revenue2.4 M2.5 M
Cost Of Revenue1.4 M1.5 M
Stock Based Compensation To Revenue 2.67  2.80 
Sales General And Administrative To Revenue 1.70  1.62 
Research And Ddevelopement To Revenue 1.07  1.02 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.02  0.01 
Ebit Per Revenue(1.94)(2.04)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kane Stock Analysis

When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY